Allogeneic or autologous bone marrow transplantation for intensification of salvage therapy in patients with high-risk advanced acute lymphoblastic leukemia. The AIEOP/GIMEMA Groups

Semin Hematol. 1991 Jul;28(3 Suppl 4):116-21.

Authors

W Arcese¹, S Amadori, G Meloni, F Giona, M L Vegna, A M Testi, L Annino, M Carotenuto, L Resegotti, E Madon, et al.

Affiliation

¹ Department of Human Biopathology, University La Sapienza, Rome, Italy.

PMID: 1780745

No abstract available

Publication types

Clinical Trial
Multicenter Study
Randomized Controlled Trial

MeSH terms

Bone Marrow Transplantation*
Chemotherapy, Adjuvant
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
Remission Induction
Survival Analysis
Transplantation, Autologous
Transplantation, Homologous